Ixinity
These highlights do not include all the information needed to use IXINITY® safely and effectively. See full prescribing information for IXINITY.. IXINITY [coagulation factor IX (recombinant)] Lyophilized Powder for Solution for Intravenous Injection Initial U.S. Approval: 2015
9521898c-61aa-44ab-8ab8-84274ca19943
HUMAN PRESCRIPTION DRUG LABEL
Feb 23, 2021
Aptevo BioTherapeutics LLC
DUNS: 080160602
Products 6
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
coagulation factor IX (recombinant)
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
coagulation factor IX (recombinant)
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
coagulation factor IX (recombinant)
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
coagulation factor IX (recombinant)
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
coagulation factor IX (recombinant)
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
coagulation factor IX (recombinant)
Product Details
FDA regulatory identification and product classification information